|
1
|
Wu Z, Weng D and Li G: Quantitative
proteome analysis of overexpressed Cripto-1 tumor cell reveals
14-3-3γ as a novel biomarker in nasopharyngeal carcinoma. J
Proteomics. 83:26–36. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Arnold M, Wildeman MA, Visser O, Karim-Kos
HE, Middeldorp JM, Fles R, Bing Tan I and Coebergh JW: Lower
mortality from nasopharyngeal cancer in The Netherlands since 1970
with differential incidence trends in histopathology. Oral Oncol.
49:237–243. 2013. View Article : Google Scholar
|
|
3
|
Jin B, Dong P, Li K, Shen B and Xie J:
Meta-analysis of the association between GSTT1 null genotype and
risk of nasopharyngeal carcinoma in Chinese. Tumour Biol.
35:345–349. 2014. View Article : Google Scholar
|
|
4
|
Sun GG, Lu YF, Fu ZZ, Cheng YJ and Hu WN:
EMP1 inhibits nasopharyngeal cancer cell growth and metastasis
through induction apoptosis and angiogenesis. Tumour Biol.
35:3185–3193. 2014. View Article : Google Scholar
|
|
5
|
Ben Chaaben A, Busson M, Douik H,
Boukouaci W, Mamoghli T, Chaouch L, Harzallah L, Dorra S, Fortier
C, Ghanem A, et al: Association of IL-12p40 +1188 A/C polymorphism
with nasopharyngeal cancer risk and tumor extension. Tissue
Antigens. 78:148–151. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li M, Dai W and Zhou H: Cyclin D1 G870A
polymorphism and risk of nasopharyngeal carcinoma: A meta-analysis.
Sci World J. 2013:6890482013.
|
|
7
|
Hildesheim A and Wang CP: Genetic
predisposition factors and nasopharyngeal carcinoma risk: A review
of epidemiological association studies, 2000–2011: Rosetta Stone
for NPC: Genetics, viral infection, and other environmental
factors. Semin Cancer Biol. 22:107–116. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Alajez NM, Shi W, Hui AB, Bruce J,
Lenarduzzi M, Ito E, Yue S, O'Sullivan B and Liu FF: Enhancer of
zeste homolog 2 (EZH2) is overexpressed in recurrent nasopharyngeal
carcinoma and is regulated by miR-26a, miR-101, and miR-98. Cell
Death Dis. 1:e852010. View Article : Google Scholar
|
|
9
|
Lee SW, Chen TJ, Lin LC, Li CF, Chen LT,
Hsing CH, Hsu HP, Tsai CJ, Huang HY and Shiue YL: Overexpression of
thymidylate synthetase confers an independent prognostic indicator
in nasopharyngeal carcinoma. Exp Mol Pathol. 95:83–90. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kim J, Jeong D, Nam J, Aung TN, Gim JA,
Park KU and Kim SW: MicroRNA-124 regulates glucocorticoid
sensitivity by targeting phosphodiesterase 4B in diffuse large B
cell lymphoma. Gene. 558:173–180. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bracken AP, Kleine-Kohlbrecher D, Dietrich
N, Pasini D, Gargiulo G, Beekman C, Theilgaard-Mönch K, Minucci S,
Porse BT, Marine JC, et al: The Polycomb group proteins bind
throughout the INK4A-ARF locus and are disassociated in senescent
cells. Genes Dev. 21:525–530. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nelson KM and Weiss GJ: MicroRNAs and
cancer: Past, present, and potential future. Mol Cancer Ther.
7:3655–3660. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Braconi C, Henry JC, Kogure T, Schmittgen
T and Patel T: The role of microRNAs in human liver cancers. Semin
Oncol. 38:752–763. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yu L, Lu J, Zhang B, Liu X, Wang L, Li SY,
Peng XH, Xu X, Tian WD and Li XP: miR-26a inhibits invasion and
metastasis of nasopharyngeal cancer by targeting EZH2. Oncol Lett.
5:1223–1228. 2013.PubMed/NCBI
|
|
15
|
Zhang LY, Ho-Fun Lee V, Wong AM, Kwong DL,
Zhu YH, Dong SS, Kong KL, Chen J, Tsao SW, Guan XY, et al:
MicroRNA-144 promotes cell proliferation, migration and invasion in
nasopharyngeal carcinoma through repression of PTEN.
Carcinogenesis. 34:454–463. 2013. View Article : Google Scholar
|
|
16
|
Deng M, Ye Q, Qin Z, Zheng Y, He W, Tang
H, Zhou Y, Xiong W, Zhou M, Li X, et al: miR-214 promotes
tumorigenesis by targeting lactotransferrin in nasopharyngeal
carcinoma. Tumour Biol. 34:1793–1800. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li G, Wu Z, Peng Y, Liu X, Lu J, Wang L,
Pan Q, He ML and Li XP: MicroRNA-10b induced by Epstein-Barr
virus-encoded latent membrane protein-1 promotes the metastasis of
human nasopharyngeal carcinoma cells. Cancer Lett. 299:29–36. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Peng XH, Huang HR, Lu J, Liu X, Zhao FP,
Zhang B, Lin SX, Wang L, Chen HH, Xu X, et al: miR-124 suppresses
tumor growth and metastasis by targeting Foxq1 in nasopharyngeal
carcinoma. Mol Cancer. 13:1862014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xu X, Li S, Lin Y, Chen H, Hu Z, Mao Y, Xu
X, Wu J, Zhu Y, Zheng X, et al: MicroRNA-124–3p inhibits cell
migration and invasion in bladder cancer cells by targeting ROCK1.
J Transl Med. 11:2762013. View Article : Google Scholar
|
|
20
|
Sonntag KC, Woo TU and Krichevsky AM:
Converging miRNA functions in diverse brain disorders: A case for
miR-124 and miR-126. Exp Neurol. 235:427–435. 2012. View Article : Google Scholar :
|
|
21
|
Liu K, Zhao H, Yao H, Lei S, Lei Z, Li T
and Qi H: MicroRNA-124 regulates the proliferation of colorectal
cancer cells by targeting iASPP. Biomed Res Int. 2013:8675372013.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li A, Lin X, Tan X, Yin B, Han W, Zhao J,
Yuan J, Qiang B and Peng X: Circadian gene Clock contributes to
cell proliferation and migration of glioma and is directly
regulated by tumor-suppressive miR-124. FEBS Lett. 587:2455–2460.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Han ZB, Yang Z, Chi Y, Zhang L, Wang Y, Ji
Y, Wang J, Zhao H and Han ZC: MicroRNA-124 suppresses breast cancer
cell growth and motility by targeting CD151. Cell Physiol Biochem.
31:823–832. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lang Q and Ling C: miR-124 suppresses cell
proliferation in hepatocellular carcinoma by targeting PIK3CA.
Biochem Biophys Res Commun. 426:247–252. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shi XB, Xue L, Ma AH, Tepper CG,
Gandour-Edwards R, Kung HJ and de Vere White RW: Tumor suppressive
miR-124 targets androgen receptor and inhibits proliferation of
prostate cancer cells. Oncogene. 32:4130–4138. 2013. View Article : Google Scholar
|
|
26
|
Xia J, Wu Z, Yu C, He W, Zheng H, He Y,
Jian W, Chen L, Zhang L and Li W: miR-124 inhibits cell
proliferation in gastric cancer through down-regulation of SPHK1. J
Pathol. 227:470–480. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang J, Lu Y, Yue X, Li H, Luo X, Wang Y,
Wang K and Wan J: miR-124 suppresses growth of human colorectal
cancer by inhibiting STAT3. PLoS One. 8:e703002013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shao H, Quintero AJ and Tweardy DJ:
Identification and charac-terization of cis elements in the STAT3
gene regulating STAT3 alpha and STAT3 beta messenger RNA splicing.
Blood. 98:3853–3856. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Aggarwal BB, Kunnumakkara AB, Harikumar
KB, Gupta SR, Tharakan ST, Koca C, Dey S and Sung B: Signal
transducer and activator of transcription-3, inflammation, and
cancer: How intimate is the relationship? Ann NY Acad Sci.
1171:59–76. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liu YP, Tan YN, Wang ZL, Zeng L, Lu ZX, Li
LL, Luo W, Tang M and Cao Y: Phosphorylation and nuclear
translocation of STAT3 regulated by the Epstein-Barr virus latent
membrane protein 1 in nasopharyngeal carcinoma. Int J Mol Med.
21:153–162. 2008.PubMed/NCBI
|
|
31
|
Lui VW, Wong EY, Ho Y, Hong B, Wong SC,
Tao Q, Choi GC, Au TC, Ho K, Yau DM, et al: STAT3 activation
contributes directly to Epstein-Barr virus-mediated invasiveness of
nasopharyngeal cancer cells in vitro. Int J Cancer. 125:1884–1893.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lee AW, Foo W, Law SC, Poon YF, O SK, Tung
SY, Sze WM, Chappell R, Lau WH and Ho JH: Staging of nasopharyngeal
carcinoma: From Ho's to the new UICC system. Int J Cancer.
84:179–187. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Alajez NM, Lenarduzzi M, Ito E, Hui AB,
Shi W, Bruce J, Yue S, Huang SH, Xu W, Waldron J, et al: miR-218
suppresses nasopharyngeal cancer progression through downregulation
of survivin and the SLIT2-ROBO1 pathway. Cancer Res. 71:2381–2391.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Xia H, Cheung WK, Ng SS, Jiang X, Jiang S,
Sze J, Leung GK, Lu G, Chan DT, Bian XW, et al: Loss of
brain-enriched miR-124 microRNA enhances stem-like traits and
invasiveness of glioma cells. J Biol Chem. 287:9962–9971. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Furuta M, Kozaki KI, Tanaka S, Arii S,
Imoto I and Inazawa J: miR-124 and miR-203 are epigenetically
silenced tumor-suppressive microRNAs in hepatocellular carcinoma.
Carcinogenesis. 31:766–776. 2010. View Article : Google Scholar
|
|
36
|
Hunt S, Jones AV, Hinsley EE, Whawell SA
and Lambert DW: MicroRNA-124 suppresses oral squamous cell
carcinoma motility by targeting ITGB1. FEBS Lett. 585:187–192.
2011. View Article : Google Scholar
|
|
37
|
Liang YJ, Wang QY, Zhou CX, Yin QQ, He M,
Yu XT, Cao DX, Chen GQ, He JR and Zhao Q: miR-124 targets Slug to
regulate epithelial-mesenchymal transition and metastasis of breast
cancer. Carcinogenesis. 34:713–722. 2013. View Article : Google Scholar :
|
|
38
|
Li L, Luo J, Wang B, Wang D, Xie X, Yuan
L, Guo J, Xi S, Gao J, Lin X, et al: MicroRNA-124 targets
flotillin-1 to regulate proliferation and migration in breast
cancer. Mol Cancer. 12:1632013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhao WH, Wu SQ and Zhang YD:
Downregulation of miR-124 promotes the growth and invasiveness of
glioblastoma cells involving upregulation of PPP1R13L. Int J Mol
Med. 32:101–107. 2013.PubMed/NCBI
|
|
40
|
Lo AK, Lo KW, Tsao SW, Wong HL, Hui JW, To
KF, Hayward DS, Chui YL, Lau YL, Takada K, et al: Epstein-Barr
virus infection alters cellular signal cascades in human
nasopharyngeal epithelial cells. Neoplasia. 8:173–180. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Li Y, Zhang Z, Liu X, Huang T, He W, Shen
Y, Liu X, Hong K and Cao Q: miR-124 functions as a tumor suppressor
in the endometrial carcinoma cell line HEC-1B partly by suppressing
STAT3. Mol Cell Biochem. 388:219–231. 2014. View Article : Google Scholar
|
|
42
|
Zeng Z, Zhou Y, Xiong W, Luo X, Zhang W,
Li X, Fan S, Cao L, Tang K, Wu M, et al: Analysis of gene
expression identifies candidate molecular markers in nasopharyngeal
carcinoma using microdissection and cDNA microarray. J Cancer Res
Clin Oncol. 133:71–81. 2007. View Article : Google Scholar
|
|
43
|
Lu J, He ML, Wang L, Chen Y, Liu X, Dong
Q, Chen YC, Peng Y, Yao KT, Kung HF, et al: miR-26a inhibits cell
growth and tumorigenesis of nasopharyngeal carcinoma through
repression of EZH2. Cancer Res. 71:225–233. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Yang EV, Sood AK, Chen M, Li Y, Eubank TD,
Marsh CB, Jewell S, Flavahan NA, Morrison C, Yeh PE, et al:
Norepinephrine up-regulates the expression of vascular endothelial
growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in
nasopharyngeal carcinoma tumor cells. Cancer Res. 66:10357–10364.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Lin ML, Lu YC, Chung JG, Wang SG, Lin HT,
Kang SE, Tang CH, Ko JL and Chen SS: Down-regulation of MMP-2
through the p38 MAPK-NF-kappaB-dependent pathway by aloe-emodin
leads to inhibition of nasopharyngeal carcinoma cell invasion. Mol
Carcinog. 49:783–797. 2010.PubMed/NCBI
|
